View Press Releases

Prescription Screening Process Analysis Provides New Possibilities for Pharmaceutical Industry

May 17, 2023


CD Formulation, a leading CRO specialized in pharmaceutical formulation, has launched a new prescription screening process analysis service for both existing and new customers across the globe. The goal is to provide drug manufacturers with accurate and reliable results. Moreover, the technology used in this process is capable of detecting impurities and other contaminants in prescription drug formulations.

Pre-prescription studies are crucial for the formulation prescribing process, which is important for assessing the drug-forming properties of compounds, selecting the appropriate dosage form, and ensuring quality control for safe and effective drugs. Pre-prescription formulation analysis involves evaluating the chemical and physical properties of drugs, which helps formulators develop stable and bioavailable dosage forms.

According to CD Formulation's management, the launch of this new service is a significant milestone for the company. "We believe that the prescription screening process analysis will help drug manufacturers save time and money while improving patient safety," he said.

Systematic pre-prescription studies will effectively guide the design of clinical formulations of drugs and the development of safe and effective, stable and controlled, easy-to-use formulations. The new service is already gaining attraction from the industry. Our dedicated team of scientists and engineers work closely with clients to develop customized solutions that meet their specific needs, the spokesperson further added.

Based on CD Formulation's strong hardware and technical capabilities in the field of pre-prescription formulation analysis, a full range of preformulation services are now available, including crystallographic screening and solid-state characterization, and physicochemical and biopharmacological characterization of active pharmaceutical ingredients (APIs). More are listed below:

  • API Physical & Chemical Characterization
  • Solid State Characterization of APIs
  • Dissolution Rate Test
  • Solubility Analysis
  • Adhesion Test
  • Crystallinity Determination
  • Particle Size Analysis
  • Powder Flowability Test
  • Determination of Contact Angle of Pharmaceutical Excipients
  • Cone Penetration Test
  • Solid Density Test
  • Bulk Density and Compaction Density Test
  • Tablet Hardness Test
  • Amorphous Content Determination
  • Hygroscopicity Evaluation
  • API-Excipient Compatibility

In addition to the prescription screening process analysis, CD Formulation also offers a range of other pharmaceutical formulation services, including stability testing, analytical method development, and formulation development. Please visit the website to learn more.


As the pharmaceutical industry continues to evolve, CD Formulation remains committed to providing innovative solutions to meet the changing needs of its clients. With its state-of-the-art technology and experienced team of experts, the company is well-positioned to help drug manufacturers overcome even the most complex formulation challenges.